PEDBASE.org - The Pediatric Database -
Detailed information of WOLMAN DISEASE
WOLMAN DISEASE
DEFINITION:
A lysosomal storage disorder characterized by the accumulation of
lipids (cholesterol and triglycerides) primarily in peripheral
tissues resulting in 2 clinical variants.
EPIDEMIOLOGY:
- incidence: ?
- age of onset:
- infancy (first weeks of life)
- risk factors:
- familial - autosomal recessive
- chrom. #: 10q24-q25
- gene: acid lipase-A isoenzyme
- M = F
PATHOGENESIS:
- acid lipase-A isoenzyme is a lysosomal hydrolase which acts
upon cholesteryl esters in various lipoproteins under acid
conditions
- first reported by Wolman and associates in 1956
2. Genetic Defect
- genetic defect -> deficiency of acid lipase-A isoenzyme
activity -> accumulation of cholesterol (esterified form) and
triglycerides in most tissues in the body, but in particular the
liver, adrenals, and intestines
- the central nervous system (CNS) is also involved but to a
lesser extent
- two clinical variants:
- acute infantile form
- severe & fatal before age 1 year (usually by 6 months)
2. Cholesteryl Ester Storage Disease - mild form
CLINICAL FEATURES:
- hepatomegaly/hepatosplenomegaly
- malabsorption with steatorrhea
- enlarged and calcified adrenals
2. Additional Gastrointestinal Manifestations
- abdominal distension
- diarrhea
- failure to thrive (FTT)
- jaundice
- vomiting - persistent and forceful
3. Others
- progressive mental deterioration
- anemia
4. Diagnosis
- the presence of bilateral adrenal calcification associated
with hepatosplenomegaly, malabsorption, and failure to thrive in
an infant
INVESTIGATIONS:
- deficiency of acid lipase-A isoenzyme activity in leukocytes
or cultured skin fibroblasts
- prenatal:
- deficiency of acid lipase-A isoenzyme activity in cultured
chorionic villi or amniocytes
2. Imaging Studies
- adrenal enlargement and calcification (present at birth)
- calcification of the adrenals is pathognomonic
- hepatosplenomegaly
3. For Malabsorption
- see "Malabsorptive Disorders"
4. Serum
- abnormal liver function tests
- conjugated hyperbilirubinemia
5. Pathology
MANAGEMENT:
- HMG-CoA reductase inhibitor
- suppresses cholesterol synthesis and apolipoprotein B
production with signficant reductions in plasma
cholesterol,triglycerides, and LDL cholesterol
- may decrease degree of hepatosplenomegaly & adrenal
dysfunction
- 20 mg po bid
|
Pediatric Database - WOLMAN DISEASE
Pediatric Organization - Pedbase [at] Gmail.com